Rx profiles

Life Underwriting Trends to Watch

Submitted by matt on Mon, 10/22/2018.

The practice of life underwriting is undergoing a lot of change as insurers look to speed up and enhance the customer experience. Big data, artificial intelligence, pharmacy records, accelerated underwriting and more are playing a part.

Link

Life Underwriting Trends to Watch

Life

life insurance

Underwriting

trends

big data

artificial intelligence

Rx profiles

accelerated underwriting

technology

The Underwriting Implications of Rx Nonadherence

Tue, 10/08/2013

The risk implications of failure to take medication as prescribed are not widely-appreciated by underwriters. To address this issue, Hank wrote a comprehensive paper on insurability issues related to nonadherence. This unique research paper was funded by Milliman Intelliscript.

Continue..

The Theory and Practice of Rx Profiling in Mortality And Morbidity Risk Underwriting

Wed, 09/23/2009

As mortality and morbidity underwriting undergoes a much-anticipated metamorphosis to accommodate the demands of the 21st century, the need for fast, reliable and cost-effective screening resources has come into clear focus. The purpose of this paper is to examine the extent to which Rx profiling is one of these resources. Knowing which pharmaceuticals an insurable applicant is taking has always been a key goal of medical history-taking. It is axiomatic that if we know what Rx an individual is taking, we have keen insight into his medical history. It is an a priori assumption, therefore, that Rx profiling services will serve to enrich our ability to relate pharmaceuticals to medical histories.

Continue..

Medical Underwriting

Rx profiles

Rx = Dx Part 2

Mon, 04/01/2002

In February, this underwriter addressed the core concept behind the odd equation Rx = Dx (pharmaceutical information and twenty-first century underwriting) and, in so doing, posited that pharmaceutical information could be effectively employed to facilitate the underwriting process.

Facilitate is a broad term.

How might knowing the exact medication a proposed insured is taking (whether prescribed or purchased over the counter) allow an underwriter to realize his twenty-first century mandate (to speed up the risk selection process) while, at the same time, not forsaking his accountability for mortality results?

Continue..

attending physicians statements (APS)

Rx = Dx Part 1

Fri, 02/01/2002

At the October 2001 conference of the Institute of Home Office Underwriters (IHOU) in Los Angeles, this underwriter presented a lecture titled, simple, “Rx = Dx.”

Fortunately, its subtitle—”Pharmaceutical Information and Twenty-First Century Underwriting”—was a tad more illuminating, and the result (thankfully) was a large audience.

The narrative translation of the curious equation might best be stated as “tell me what he’s taking and I’ll tell you what he’s got.”